0001179110-19-006151.txt : 20190516 0001179110-19-006151.hdr.sgml : 20190516 20190516161314 ACCESSION NUMBER: 0001179110-19-006151 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190515 FILED AS OF DATE: 20190516 DATE AS OF CHANGE: 20190516 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kollender Richard S CENTRAL INDEX KEY: 0001415666 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37569 FILM NUMBER: 19832376 MAIL ADDRESS: STREET 1: C/O QUAKER BIOVENTURES, CIRA CENTRE STREET 2: 2929 ARCH STREET, 3RD FLOOR CITY: PHILADELPHIA STATE: PA ZIP: 19104-2868 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Strongbridge Biopharma plc CENTRAL INDEX KEY: 0001634432 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981130690 STATE OF INCORPORATION: L2 BUSINESS ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 BUSINESS PHONE: (610) 254-9200 MAIL ADDRESS: STREET 1: 900 NORTHBROOK DRIVE, SUITE 200 CITY: TREVOSE STATE: PA ZIP: 19053 FORMER COMPANY: FORMER CONFORMED NAME: Cortendo AB DATE OF NAME CHANGE: 20150219 4 1 edgar.xml FORM 4 - X0306 4 2019-05-15 0 0001634432 Strongbridge Biopharma plc SBBP 0001415666 Kollender Richard S 900 NORTHBROOK DRIVE SUITE 200 TREVOSE PA 19053 1 0 0 0 Ordinary Shares 2019-05-15 4 A 0 40000 0 A 40000 D Represents a grant of restricted stock units, which vest in full on May 15, 2020, provided that the Reporting Person continues to serve as a member of the board of directors of the Issuer through that date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. /s/ Judith Goldberg, as attorney-in-fact 2019-05-16